Effects of 4'-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart.
about
Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseasesTranslocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotraumaMechanisms of sudden cardiac death: oxidants and metabolismThe scale-free dynamics of eukaryotic cellsMitochondrial network energetics in the heart.Glutathione oxidation as a trigger of mitochondrial depolarization and oscillation in intact hearts.High-precision recording of the action potential in isolated cardiomyocytes using the near-infrared fluorescent dye di-4-ANBDQBS.Mitochondrial depolarization and electrophysiological changes during ischemia in the rabbit and human heartA reaction-diffusion model of ROS-induced ROS release in a mitochondrial networkAltered spatiotemporal dynamics of the mitochondrial membrane potential in the hypertrophied heart.Mitochondria and arrhythmias.Functional crosstalk between the mitochondrial PTP and KATP channels determine arrhythmic vulnerability to oxidative stress4'-Chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during postischemia reperfusion in rats.Potential therapeutic benefits of strategies directed to mitochondria.Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel.Cardiac mitochondria and arrhythmias.Mitochondrial instability during regional ischemia-reperfusion underlies arrhythmias in monolayers of cardiomyocytesOptical imaging of mitochondrial function uncovers actively propagating waves of mitochondrial membrane potential collapse across intact heart.Mitochondrial energetics, pH regulation, and ion dynamics: a computational-experimental approach.Mitochondria are sources of metabolic sink and arrhythmias.ROS-induced ROS release in vascular biology: redox-redox signaling.Metabolic stress, reactive oxygen species, and arrhythmia.Exercise-induced protection against reperfusion arrhythmia involves stabilization of mitochondrial energeticsCardiac mitochondrial network excitability: insights from computational analysis.Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide.Nanosecond pulsed platelet-rich plasma (nsPRP) improves mechanical and electrical cardiac function following myocardial reperfusion injury.Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathyRegulation and pharmacology of the mitochondrial permeability transition pore.Modeling cardiac action potential shortening driven by oxidative stress-induced mitochondrial oscillations in guinea pig cardiomyocytes.From mitochondrial dynamics to arrhythmias.Cardiac metabolism and arrhythmias.Exercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart.Mitochondrial targets for arrhythmia suppression: is there a role for pharmacological intervention?The mitochondrial translocator protein and arrhythmogenesis in ischemic heart diseaseCardiac arrhythmias induced by glutathione oxidation can be inhibited by preventing mitochondrial depolarization.Is suvorexant a better choice than alternative hypnotics?Redox-optimized ROS balance: a unifying hypothesisHigh doses of ketamine-xylazine anesthesia reduce cardiac ischemia-reperfusion injury in guinea pigs.Melatonin, given at the time of reperfusion, prevents ventricular arrhythmias in isolated hearts from fructose-fed rats and spontaneously hypertensive rats.Functional Role of Mitochondria in Arrhythmogenesis.
P2860
Q24602947-E4C0805D-0D35-4963-9F8E-ACEDBEE2B348Q24649929-48C950AD-B83D-495A-9E0F-BCAAE28A40FFQ27024176-592C0C95-3B7F-41A2-9212-3F580C8483ABQ27438156-9FC643B5-868B-4E6E-8385-D3EE282D5B0BQ27691332-C8571C26-8FFA-4D59-A76C-2F87A4584DF8Q30485060-F225012A-59DA-43C8-A830-259A68B2F920Q30497050-E0BC8A5B-2C00-49FA-B39A-1D9F02CC1643Q30593498-25998803-F8B5-4E10-84D6-6ECE3CAA8174Q33529043-849FB676-6FEC-4901-A6DF-361B2C85FA57Q33581595-D7301D43-E2A5-4FE8-ACA1-786696D67088Q33896746-C0DF66F4-5960-4F0E-BE35-9ACD64F6F10FQ33906966-1F6624A7-0260-447D-AF4E-4FCD582F23ABQ34111148-828BD949-C4A7-4F69-8193-C384439F7583Q34117168-A144BBF4-2797-457B-AF53-1645823F9483Q34204033-01924CA5-E183-4818-84D0-2427A411B537Q34307966-9D220718-DF0B-422D-97EB-31C68CD48A94Q34441051-D019F20B-C333-4A0B-B328-82A9C69C7670Q34840891-61CAE043-8D58-4EBF-9FC8-2EA34095BD3FQ35070487-DBC81155-3018-4FFD-BFF6-05B9FCEA5003Q35111783-3E20D525-88AA-469A-9B76-E356EB3767C0Q35314786-9EF54855-DA3A-446B-B8C6-634E9A80CF4EQ35690954-90F02EC6-B688-425E-8FC4-2EB1CCA7B54FQ35946411-317FC693-DB29-46D3-9BD2-D16515B04063Q36042642-1E2D4684-E912-48A3-B7C2-DC6F7C89AB8FQ36366202-40ED0C80-F804-4D04-8640-42A5C5672DD5Q36754302-FDF57680-013E-4060-99B0-7C71F86EE9DBQ37091220-2101750F-ADD1-4F5E-B14E-6DC0F641DDABQ37240968-42FDE339-A51B-4ED6-A35F-FECF470B4582Q37373389-2A872532-817D-4DED-B056-6DBEBA0ABD49Q37585747-28B692C6-BA62-4601-BEA1-DEBC31B3C0E8Q37609734-1FC32B16-A26A-4C50-B3F4-122EE1C9969EQ37851768-867455A3-C894-4FF9-B80C-6BD5E5DD9439Q38119177-943D14E5-E05E-4DEB-A82D-57A2B75B069CQ38445775-1580404A-13E7-41AD-AE94-CD2FE3608DEDQ39599713-CF279B84-5C45-4E9D-8C25-22EB9FDB5F85Q40900071-FE6C1CD3-E6EB-4D5B-A378-D740E09EA408Q41441153-129B650A-1EF1-4586-9279-70E0F54D7AA3Q42740264-99180F03-DAA4-4DD3-8702-1EA2AA917D75Q44188620-6617F4F1-B7F7-4355-8DDC-4150280C16FDQ46359842-95D8427F-8976-4088-8C79-D43361D81B26
P2860
Effects of 4'-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Effects of 4'-chlorodiazepam o ...... fusion injury in rabbit heart.
@en
type
label
Effects of 4'-chlorodiazepam o ...... fusion injury in rabbit heart.
@en
prefLabel
Effects of 4'-chlorodiazepam o ...... fusion injury in rabbit heart.
@en
P2093
P2860
P356
P1476
Effects of 4'-chlorodiazepam o ...... fusion injury in rabbit heart.
@en
P2093
Brian O'Rourke
David A Brown
Fadi G Akar
Miguel A Aon
Nicolas Sorarrain
P2860
P304
P356
10.1093/CVR/CVN053
P577
2008-02-26T00:00:00Z